Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 38.60
-0.60 (-1.53%)
Oct 10, 2025, 5:29 PM CET
Hansa Biopharma AB Revenue
Hansa Biopharma AB had revenue of 49.12M SEK in the quarter ending June 30, 2025, with 43.07% growth. This brings the company's revenue in the last twelve months to 196.47M, up 20.12% year-over-year. In the year 2024, Hansa Biopharma AB had annual revenue of 171.32M with 27.76% growth.
Revenue (ttm)
196.47M
Revenue Growth
+20.12%
P/S Ratio
16.65
Revenue / Employee
1.40M
Employees
135
Market Cap
3.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 171.32M | 37.22M | 27.76% |
| Dec 31, 2023 | 134.09M | -20.43M | -13.22% |
| Dec 31, 2022 | 154.53M | 120.65M | 356.12% |
| Dec 31, 2021 | 33.88M | 27.78M | 455.56% |
| Dec 31, 2020 | 6.10M | 2.73M | 81.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.97B |
| Sectra AB | 3.37B |
| Getinge AB | 35.50B |
| Camurus AB | 2.27B |
| Medicover AB | 25.22B |
| Asker Healthcare Group AB | 15.88B |
| BioArctic AB | 1.86B |
| AddLife AB | 10.44B |
Hansa Biopharma AB News
- 16 days ago - Hansa Biopharma AB (publ) Discusses on ConfIdeS US Phase 3 Pivotal Trial Topline Results Presentation - Seeking Alpha
- 16 days ago - Hansa Biopharma AB (publ) - Special Call - Seeking Alpha
- 16 days ago - Hansa Biopharma AB (Publ) Discusses On ConfIdeS US Phase 3 Pivotal Trial Topline Results Call (Transcript) - Seeking Alpha
- 2 months ago - Hansa Biopharma announces key executive appointments to support continued growth - PRNewsWire
- 3 months ago - Hansa Biopharma AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results - PRNewsWire
- 3 months ago - Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer - PRNewsWire